Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04126070
Title Nivolumab + Docetaxel + ADT in Metastatic Hormone Sensitive Prostate Cancer
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Xiao X. Wei
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.